These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8527467)

  • 1. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls.
    Pichot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):306-8. PubMed ID: 8527467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic function in panic disorder: comparison with major and minor depression.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M; von Frenckell R
    Biol Psychiatry; 1992 Dec; 32(11):1004-11. PubMed ID: 1467380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Neuropsychobiology; 1995; 32(1):19-22. PubMed ID: 7566518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone response to apomorphine at 4 days postpartum in women with a history of major depression.
    Mc Ivor RJ; Davies RA; Wieck A; Marks MN; Brown N; Campbell IC; Checkley SA; Kumar R
    J Affect Disord; 1996 Oct; 40(3):131-6. PubMed ID: 8897112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced dopaminergic activity in depressed suicides.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Fuchs S; Pirard S; Ansseau M
    Psychoneuroendocrinology; 2001 Apr; 26(3):331-5. PubMed ID: 11166495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine evaluation of catecholaminergic neurotransmission in mania.
    Ansseau M; von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Psychiatry Res; 1987 Nov; 22(3):193-206. PubMed ID: 2829258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M
    Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression.
    Ansseau M; Von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Br J Psychiatry; 1988 Jul; 153():65-71. PubMed ID: 3224252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathological correlates of dopaminergic disturbances in major depression.
    Pitchot W; Hansenne M; Moreno AG; von Frenckell R; Ansseau M
    Neuropsychobiology; 1990-1991; 24(4):169-72. PubMed ID: 2135707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphine in normal subjects.
    Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Guyda H
    J Psychiatry Neurosci; 1996 Mar; 21(2):96-100. PubMed ID: 8820174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients.
    Müller-Spahn F; Modell S; Ackenheil M; Brachner A; Kurtz G
    J Psychiatr Res; 1998; 32(5):265-71. PubMed ID: 9789204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine in non-depressed patients with a history of suicide attempts.
    Pitchot W; Hansenne M; Ansseau M
    Eur Psychiatry; 2001 Nov; 16(7):424-7. PubMed ID: 11728856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Pinto E; Reggers J; Fuchs S; Pirard S; Ansseau M
    Psychoneuroendocrinology; 2001 Oct; 26(7):689-96. PubMed ID: 11500250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal behavior and growth hormone response to apomorphine test.
    Pitchot W; Hansenne M; Moreno AG; Ansseau M
    Biol Psychiatry; 1992 Jun; 31(12):1213-9. PubMed ID: 1391282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis dysfunction in depression: correlation with monoamine system abnormalities.
    Mokrani MC; Duval F; Crocq MA; Bailey P; Macher JP
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S63-8. PubMed ID: 9264149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of the sleep EEG as a biological marker of depressive states. Comparison with 3 neuroendocrine tests].
    Ansseau M; Scheyvaerts M; Doumont A; Poirrier R; Demonceau G; Legros JJ; Franck G
    Rev Electroencephalogr Neurophysiol Clin; 1985 Apr; 14(4):343-9. PubMed ID: 4023361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.